Xtant Medical Holdings (XTNT) Price to FCF (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Price to FCF for 16 consecutive years, with 21.72 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Price to FCF rose 188.57% year-over-year to 21.72 in Q3 2025; TTM through Sep 2025 was 17.57, a 423.77% increase from a year earlier, with the FY2024 full-year figure at 3.85, up 71.3% from the prior year.
• Price to FCF was 21.72 for Q3 2025 at Xtant Medical Holdings, down from 113.14 in the prior quarter.
• Over five years, Price to FCF peaked at 751.36 in Q1 2025 and troughed at 8799.6 in Q4 2024.
• A 5-year average of 461.43 and a median of 28.51 in 2022 frame the typical range for Price to FCF.
• Across the five-year window, Price to FCF tumbled 7544.89% in 2024 and soared 3319.42% in 2025, its largest moves.
• Over 5 years, Price to FCF stood at 240.19 in 2021, then surged by 89.05% to 26.31 in 2022, then slumped by 337.46% to 115.1 in 2023, then plunged by 7544.89% to 8799.6 in 2024, then jumped by 100.25% to 21.72 in 2025.
• The last three Price to FCF figures came in at 21.72 (Q3 2025), 113.14 (Q2 2025), and 751.36 (Q1 2025), per Business Quant data.